Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
2.
J Am Acad Dermatol ; 75(6): 1176-1186.e4, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27502312

ABSTRACT

BACKGROUND: Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas. OBJECTIVE: We sought to determine whether IMS can assist in the classification of diagnostically challenging atypical Spitzoid neoplasms (ASN), to compare and correlate the IMS and histopathological diagnoses with clinical behavior. METHODS: We conducted a retrospective collaborative study involving centers from 11 countries and 11 US institutions analyzing 102 ASNs by IMS. Patients were divided into clinical groups 1 to 4 representing best to worst clinical behavior. The association among IMS findings, histopathological diagnoses, and clinical groups was assessed. RESULTS: There was a strong association between a diagnosis of Spitzoid melanoma by IMS and lesions categorized as clinical groups 2, 3, and 4 (recurrence of disease, metastases, or death) compared with clinical group 1 (no recurrence or metastasis beyond a sentinel node) (P < .0001). Older age and greater tumor thickness were strongly associated with poorer outcome (P = .01). CONCLUSIONS: IMS diagnosis of ASN better predicted clinical outcome than histopathology. Diagnosis of Spitzoid melanoma by IMS was strongly associated with aggressive clinical behavior. IMS analysis using a proteomic signature may improve the diagnosis and prediction of outcome/risk stratification for patients with ASN.


Subject(s)
Mass Spectrometry , Melanoma/diagnostic imaging , Melanoma/secondary , Neoplasm Recurrence, Local/diagnostic imaging , Neoplasm Recurrence, Local/pathology , Nevus, Epithelioid and Spindle Cell/diagnostic imaging , Nevus, Epithelioid and Spindle Cell/pathology , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/pathology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Child, Preschool , Diagnosis, Differential , Female , Humans , Lymphatic Metastasis , Male , Melanoma/chemistry , Middle Aged , Neoplasm Recurrence, Local/chemistry , Nevus, Epithelioid and Spindle Cell/chemistry , Proteins/analysis , Retrospective Studies , Risk Assessment , Sentinel Lymph Node Biopsy , Skin Neoplasms/chemistry , Treatment Outcome , Tumor Burden , Young Adult
3.
Mol Cancer Ther ; 13(12): 3210-8, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25319388

ABSTRACT

BRAF inhibitors (BRAFi) have led to clinical benefit in patients with melanoma. The development of a blood-based assay to detect and quantify BRAF levels in these patients has diagnostic, prognostic, and predictive capabilities that could guide treatment decisions. Blood BRAF(V600E) detection and quantification were performed on samples from 128 patients with stage II (19), III (67), and IV (42) melanoma. Tissue BRAF analysis was performed in all patients with stage IV disease and in selected patients with stage II and III disease. Clinical outcomes were correlated to initial BRAF levels as well as BRAF level dynamics. Serial analysis was performed on 17 stage IV melanoma patients treated with BRAFi and compared with tumor measurements by RECIST. The assay was highly sensitive (96%) and specific (95%) in the stage IV setting, using a blood level of 4.8 pg as "positive." BRAF levels typically decreased following BRAFi. A subset of these patients (5) had an increase in BRAF(V600E) values 42 to 112 days before clinical or radiographic disease progression (PD). From 86 patients with resected, stage II or III melanoma, 39 had evidence of disease relapse (45.3%). Furthermore, BRAF mutation in the blood after surgical resection in these patients was not associated with a difference in relapse risk, although tissue BRAF status was only available for a subset of patients. In summary, we have developed a highly sensitive and specific, blood-based assay to detect BRAF(V600) mutation in patients with melanoma.


Subject(s)
DNA Mutational Analysis/methods , Melanoma/diagnosis , Melanoma/genetics , Mutation , Proto-Oncogene Proteins B-raf/genetics , Amino Acid Substitution , Cell Line, Tumor , Codon , DNA Mutational Analysis/standards , Genotype , Humans , Leukocytes, Mononuclear , Melanoma/drug therapy , Molecular Targeted Therapy , Neoplasm Staging , Proto-Oncogene Proteins B-raf/antagonists & inhibitors , Reproducibility of Results , Sensitivity and Specificity
4.
Pediatr Dermatol ; 31(5): 584-7, 2014.
Article in English | MEDLINE | ID: mdl-24913904

ABSTRACT

A number of lesions have been documented to arise within congenital melanocytic nevi (CMNs). Although the most frequent malignancy arising within a CMN is melanoma, the association between rhabdomyosarcoma and CMN has rarely been documented. We present a case arising in a 4-month-old girl with a giant CMN. She presented for evaluation of a pedunculated lesion at the superior gluteal crease that had been present since birth and exhibited rapid growth. Biopsy of the lesion revealed two distinct components: an expansile proliferation of pleomorphic cells with varying degrees of cellularity and a proliferation of banal-appearing melanocytic nevic cells. The cells of the expansile proliferation displayed a wide range of morphologic features, including nests of round cells, spindle-shaped cells, and more differentiated rhabdomyoblasts within a myxoid, highly vascularized stroma. Cross-striations, a marker of skeletal muscle differentiation, were present. These tumor cells were strongly immunoreactive with desmin, myo-D1, and myogenin. Fluorescence in situ hybridization analysis with PAX3/7-FKHR probes was negative. A diagnosis of embryonal rhabdomyosarcoma in association with CMN was made. Initial excision revealed tumor at the margins, and the patient underwent reexcision with subsequent chemotherapy with vincristine, actinomycin D, and cyclophosphamide. She was disease-free at the 6-year follow-up. It has been postulated that the combination of melanocytic and rhabdomyoblastic cells within the same lesion may imply derivation from a common pluripotent stem cell or neural crest cell. Clinicians following patients with giant CMN should consider rhabdomyosarcoma in the differential diagnosis of lesions arising within the nevus.


Subject(s)
Nevus, Pigmented/congenital , Rhabdomyosarcoma, Embryonal/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Female , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Infant , Nevus, Pigmented/therapy , Rhabdomyosarcoma, Embryonal/pathology , Rhabdomyosarcoma, Embryonal/therapy , Staining and Labeling
5.
Arch Iran Med ; 16(1): 46-53, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23273237

ABSTRACT

BACKGROUND: The Gastro-Esophageal Malignancies in Northern Iran (GEMINI) research project is an example of recent progress in health research in Iran. The original aim of this project was to identify etiologic factors and prevention measures for upper gastrointestinal cancers in Northern provinces of Iran, but its achievements have gone much beyond this initial goal. METHODS: GEMINI consists of several projects including cancer registries, pilot studies, case-control studies, and the Golestan Cohort Study. GEMINI has been conducted through extensive collaborations between the Digestive Disease Research Center of Tehran University of Medical Sciences with other domestic and international health organizations. The achievements of GEMINI include producing new knowledge, introducing new research methods, developing and expanding health research and health care infrastructures, investing in human resources, and increasing the awareness and knowledge of policy makers and officials at all levels about the importance of chronic diseases in Iran's health priorities. CONCLUSION: The success of GEMINI reveals the feasibility of large-scale health research studies in developing countries and serves as a successful model not only for health research in Iran, but also for similar research studies in other developing nations.


Subject(s)
Biomedical Research/organization & administration , Developing Countries , Esophageal Neoplasms , Stomach Neoplasms , Biomedical Research/methods , Chronic Disease , Delivery of Health Care/methods , Delivery of Health Care/organization & administration , Esophageal Neoplasms/etiology , Esophageal Neoplasms/prevention & control , Health Policy , Humans , Iran , Registries , Research Design , Stomach Neoplasms/etiology , Stomach Neoplasms/prevention & control
6.
J Cutan Pathol ; 40(1): 61-5, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23278726

ABSTRACT

Markedly pleomorphic epithelioid cells with high mitotic activity, giant cell formation, very large atypical nuclei, multiple nucleoli and abundant cytoplasm characterize 'monster' cells and may indicate aggressive tumor behavior. Very rare reports of melanomas comprised of 'monster cells' or cells with comparable histomorphological features, found in tissue samples from skin, lymph nodes, CNS, oral cavity and ileum have been published in the literature. This case is the first such description in the lung, and it is characterized with a battery of immunohistochemical stains; BRAF mutation status was negative, and fluorescence in situ hybridization analysis revealed increased copy number gains in 11q (cyclin D1), which is associated with poor prognosis in melanoma. The presence of monster cells in melanoma was associated with aggressive behavior in the reported patient.


Subject(s)
Cyclin D1/genetics , Giant Cells/pathology , Lung Neoplasms/secondary , Melanoma/pathology , Skin Neoplasms/pathology , Fatal Outcome , Female , Giant Cells/physiology , Humans , Lung Neoplasms/genetics , Melanoma/genetics , Middle Aged , Skin Neoplasms/genetics
7.
Arch Pathol Lab Med ; 136(11): 1430-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23106589

ABSTRACT

CONTEXT: There are few published examples of pathology instruction during the clinical years of medical student training. This lack of exposure to pathology may lead to poor understanding of laboratory testing and the role of pathologists in patient care. OBJECTIVE: To design, implement, and evaluate a pathology curriculum integrated into a longitudinal clerkship for third-year medical students. DESIGN: The curriculum includes an introductory session during the transition week course, pathologist participation in longitudinal student case conferences, and a pathology elective. The curriculum was evaluated by using surveys consisting of both multiple choice and written responses. RESULTS: A total of 55 students participated in the longitudinal curriculum during the 2009-2010 academic year and 8 students, only one of whom stated a career interest in pathology, participated in the elective. More than 80 pathology topics were discussed and, for the first time, pathologists received teaching awards from the third-year students. All elective students would recommend the elective to colleagues; feedback also suggested an improved understanding of pathology as a profession. At the end of the year, 31% of all students, compared to only 19% in the initial survey, knew that most of an anatomic pathologist's caseload consists of specimens from living patients (P  =  .13). In addition, elective student interaction with a pathology faculty member directly led to an improvement in test reporting. CONCLUSIONS: A novel longitudinal curriculum allowed for the creative integration of pathology into third-year students' clinical training and led to better student understanding of the role of pathologists in patient care.


Subject(s)
Pathology, Clinical/education , Boston , Curriculum , Education, Medical, Undergraduate , Humans , Schools, Medical
8.
J Am Acad Dermatol ; 67(5): 945-54, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22445215

ABSTRACT

BACKGROUND: We report a series of patients initially given the diagnosis of necrotizing fasciitis whose course progressed despite surgical debridement, antibiotic therapy, or both, but who responded rapidly to systemic corticosteroids. OBJECTIVE: We sought to evaluate the clinical data, histopathologic and microbiology information, and treatment course of this unusual entity. METHODS: This was a descriptive study/case series. RESULTS: Three immunocompromised patients who presented with signs and symptoms of necrotizing fasciitis were included. They appeared septic, failed multiple courses of antibiotics, demonstrated pathergy, and two of them underwent extensive surgical debridement. None of the cases yielded a microbial source. Dermatologic consultation and histopathology confirmed deep Sweet syndrome in all cases, with marked necrosis of the soft tissue--including myonecrosis--in the two patients with debridement. All patients responded rapidly to high-dose systemic corticosteroids. LIMITATIONS: To our knowledge, this is the first report of this unusual presentation; there are a limited number of cases. CONCLUSION: We propose that these cases represent a new variant of neutrophilic dermatosis: "necrotizing Sweet syndrome," an acute necrotizing neutrophilic dermatosis. This subtype is also characterized by the rapid onset of progressive erythematous, warm, edematous cutaneous lesions with deep-tissue neutrophilic infiltration and soft-tissue necrosis, in the absence of infectious cause. Awareness of this entity and early dermatologic consultation is critical as debridement results in expansion of the process, resulting in additional and aggressive resection--a vicious cycle with significant possible morbidity.


Subject(s)
Fasciitis, Necrotizing/diagnosis , Sweet Syndrome/diagnosis , Acute Disease , Adrenal Cortex Hormones/administration & dosage , Adult , Aged, 80 and over , Debridement , Diagnosis, Differential , Disease Progression , Fasciitis, Necrotizing/drug therapy , Humans , Immunocompromised Host , Male , Middle Aged , Necrosis , Risk Factors , Subcutaneous Tissue/pathology , Sweet Syndrome/pathology , Sweet Syndrome/surgery
9.
PLoS One ; 7(3): e32711, 2012.
Article in English | MEDLINE | ID: mdl-22396792

ABSTRACT

BACKGROUND: Control selection is a major challenge in epidemiologic case-control studies. The aim of our study was to evaluate using hospital versus neighborhood control groups in studying risk factors of esophageal squamous cell carcinoma (ESCC). METHODOLOGY/PRINCIPAL FINDINGS: We compared the results of two different case-control studies of ESCC conducted in the same region by a single research group. Case definition and enrollment were the same in the two studies, but control selection differed. In the first study, we selected two age- and sex-matched controls from inpatient subjects in hospitals, while for the second we selected two age- and sex-matched controls from each subject's neighborhood of residence. We used the test of heterogeneity to compare the results of the two studies. We found no significant differences in exposure data for tobacco-related variables such as cigarette smoking, chewing Nass (a tobacco product) and hookah (water pipe) usage, but the frequency of opium usage was significantly different between hospital and neighborhood controls. Consequently, the inference drawn for the association between ESCC and tobacco use did not differ between the studies, but it did for opium use. In the study using neighborhood controls, opium use was associated with a significantly increased risk of ESCC (adjusted OR 1.77, 95% CI 1.17-2.68), while in the study using hospital controls, this was not the case (OR 1.09, 95% CI 0.63-1.87). Comparing the prevalence of opium consumption in the two control groups and a cohort enrolled from the same geographic area suggested that the neighborhood controls were more representative of the study base population for this exposure. CONCLUSIONS/SIGNIFICANCE: Hospital and neighborhood controls did not lead us to the same conclusion for a major hypothesized risk factor for ESCC in this population. Our results show that control group selection is critical in drawing appropriate conclusions in observational studies.


Subject(s)
Carcinoma, Squamous Cell/etiology , Esophageal Neoplasms/etiology , Opium/adverse effects , Adult , Age Factors , Aged , Case-Control Studies , Female , Hospitals , Humans , Inpatients , Iran , Male , Middle Aged , Prevalence , Research Design , Residence Characteristics , Risk Factors , Sex Factors , Smoking/adverse effects
11.
Dermatol Online J ; 18(1): 3, 2012 Jan 15.
Article in English | MEDLINE | ID: mdl-22301040

ABSTRACT

We describe a patient with pemphigus foliaceus who developed two distinct disseminated cutaneous viral infections. Our patient is an 83-year-old female with a recent diagnosis of pemphigus foliaceus, who presented with painful ulcerations while on corticosteroids. Histopathology examination revealed disseminated herpes simplex virus (HSV). Despite adequate treatment with anti-herpetic treatment, some ulcerations failed to heal. A second biopsy revealed the presence of cytomegalovirus (CMV). This was treated successfully with appropriate antiviral therapy. In patients with autoimmune bullous disease, the development of new skin pain or new constitutional symptoms, change in primary morphology, rapid disease progression, or failure to respond to appropriate therapies should prompt the clinician to consider a concurrent cutaneous viral infection. There should be a low threshold to perform ancillary tests, to re-biopsy, and in severe cases, to consider empiric treatment with antiviral treatment therapy and modification of immunosuppressive regimens.


Subject(s)
Cytomegalovirus Infections/complications , Herpes Simplex/complications , Pemphigus/complications , Acyclovir/therapeutic use , Aged, 80 and over , Anti-Inflammatory Agents/therapeutic use , Antiviral Agents/therapeutic use , Cytomegalovirus Infections/drug therapy , Female , Ganciclovir/analogs & derivatives , Ganciclovir/therapeutic use , Herpes Simplex/drug therapy , Humans , Pemphigus/drug therapy , Prednisolone/therapeutic use , Valganciclovir
12.
J Am Acad Dermatol ; 65(6): 1073-84, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22082838

ABSTRACT

Spitz nevi are melanocytic proliferations that are characterized by spindled and/or epithelioid nevomelanocytes. First interpreted as juvenile melanoma, these lesions were later characterized as benign and were observed to affect all age groups. Today, contrasting opinions persist regarding the fundamental benignancy versus malignancy within the spectrum of Spitz tumors. Beyond clinical outcome, this controversy has also been fueled by complex and sometimes convoluted classification schemes based on pathologic characteristics. More recently, immunophenotypic and molecular analyses have begun to clarify the etiologic nature of these tumors. Recent evidence suggests that histopathologic features that suggest more aggressiveness in Spitz tumors relate to mitoses and inflammation.


Subject(s)
Nevus, Epithelioid and Spindle Cell/pathology , Skin Neoplasms/pathology , Humans
13.
J Am Acad Dermatol ; 65(6): 1087-92, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22082839

ABSTRACT

For dermatologists, evidence-based management guidelines for Spitz tumors have not been established. Despite the lack of a standardized approach, most dermatologists recommend the excision of Spitz tumors occurring in adults and adopt more conservative measures towards pediatric cases. The histopathologic attributes and the clinical scenario are factored into management in each case. While the metastatic behavior of certain Spitz tumors is well known, the malignant potential of these lesions remains unclear because they only rarely result in negative outcomes. The risks and benefits of adjunctive measures, such as sentinel lymph node biopsy and interferon use, remain untested and are subjects of ongoing controversy. (In part II of this continuing medical education article, we will continue to use the terminology defined in part I for purposes of continuity. "Spitz tumor" is used as the umbrella term for the entire category of lesions, "common Spitz nevi" refers to only the most typical lesions seen in pediatric cases, and "atypical Spitz tumors" encompass the "all other" category, which continues to cause debate.).


Subject(s)
Nevus, Epithelioid and Spindle Cell/therapy , Skin Neoplasms/therapy , Humans , Nevus, Epithelioid and Spindle Cell/pathology , Sentinel Lymph Node Biopsy , Skin Neoplasms/pathology
14.
Arch Iran Med ; 14(5): 357-8, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21888463

ABSTRACT

Heterotopic pancreas is defined as pancreatic tissue arising ectopically with no vascular or anatomic contiguity with the pancreas proper and is believed to arise embryologically during rotation of the foregut and fusion of the dorsal and ventral pancreatic buds. We report a case of gastric heterotopic pancreas presenting as an obstructive inflammatory mass with the clinical differential diagnosis of gastric carcinoma. A 54 year-old woman presented with a history of four days of severe, acute-onset abdominal pain. Abdominal ultrasound showed a gastric antral mass. This was confirmed on computerized tomography, which revealed a hypo-dense mass with heterogeneous enhancement in the gastric antrum and multiple ill-defined hypo-dense areas in the liver suspicious for metastases. A preoperative diagnosis of malignant neoplasm was strongly favored, and a subtotal gastrectomy was performed. Microscopic examination of the specimen revealed submucosal and deeply seated intra-muscular and mural heterotopic pancreatic tissue, comprised of both ductal and acinar structures, surrounded by exuberant acute and chronic inflammation. The ducts were inflamed and showed marked cytologic atypia, favored to be of reactive nature. There was overlying mucosal ulceration with marked acute and chronic full-thickness gastric mural inflammatory response with abscess formation. This is the second reported case of obstructive gastric heterotopic pancreas, presenting as an inflammatory mural gastric mass.


Subject(s)
Choristoma/pathology , Gastrectomy , Pancreas , Stomach Diseases , Stomach Neoplasms/diagnosis , Stomach/pathology , Abdominal Pain/physiopathology , Biopsy , Diagnosis, Differential , Female , Humans , Middle Aged , Postoperative Care , Stomach/surgery , Stomach Diseases/pathology , Stomach Diseases/physiopathology , Stomach Diseases/surgery , Tomography, X-Ray Computed , Treatment Outcome
15.
J Cutan Pathol ; 38(12): 984-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21752054

ABSTRACT

The pigmented purpuric dermatoses (PPD) are a group of diseases characterized by petechiae and bronze discoloration of the skin on the lower extremities. Histopathologically, extravasation of erythrocytes with hemosiderin deposition, a perivascular lymphocytic infiltrate centered on the superficial capillaries and endothelial cell swelling are seen. The granulomatous variant of PPD (GPPD) was described in 1996 and only 10 cases have been reported since in the literature, almost exclusively in patients of East Asian descent only involving the extremities. We present a case of GPPD in a Caucasian, North American Ashkenazi Jewish woman involving the thighs, back, forearms and wrists with concomitant non-granulomatous PPD of the shins. She presented with an asymptomatic, spreading, cayenne pepper-like rash. This rash intermittently involved the lower extremities and back for 15 years, but now involves the thighs with accompanying pink papules on the back, wrists and forearms. Histopathology of the thigh and back lesions revealed superficial lichenoid granulomatous dermatitis with palisading lymphocytes and focal interface changes. Extravasated erythrocytes were seen, but vasculitis was absent. No lymphocytic atypicality was noted and T-cell gene rearrangement studies were non-clonal. This is the second reported case of GPPD in a non-Asian patient and the first case involving sites other than the extremities.


Subject(s)
Dermatitis/metabolism , Dermatitis/pathology , Purpura/metabolism , Purpura/pathology , Skin/metabolism , Skin/pathology , Dermatitis/ethnology , Female , Humans , Jews , Middle Aged , Purpura/ethnology , White People
16.
Dermatol Online J ; 17(5): 2, 2011 May 15.
Article in English | MEDLINE | ID: mdl-21635824

ABSTRACT

We report on a 43-year-old Caucasian female who presented with bright red macules in a unilateral distribution in the left C5-8 and L3-5 dermatomes. Histopathologic examination showed superficial papillary dermal telangiectasia with minimal chronic inflammation. Immunohistochemical stains for estrogen and progesterone receptors (ER/PR) were negative. A diagnosis of unilateral nevoid telangiectasia syndrome (UNTS) was given. UNTS is an uncommon disorder first described by Alfred Blaschko in 1899. It is comprised of telangiectasias occurring in a predominantly unilateral dermatomal distribution and often affecting the trigeminal, cervical, and upper thoracic dermatomes. It can be either congenital or acquired and has a 2:1 female:male ratio. UNTS has been reported in relation to hyperestrogenic states, with half of the reported cases related to pregnancy, puberty, or liver disease. However, the vast majority of cases show no increase in estrogen and progesterone receptors in lesional skin. UNTS may be more common than previously believed, and shows some response to vascular laser therapy. Differential diagnoses include hemangioma, angioma serpiginosum, and rarely, nevus flammeus.


Subject(s)
Telangiectasis/diagnosis , Adult , Diagnosis, Differential , Female , Hemangioma/diagnosis , Humans , Models, Biological , Port-Wine Stain/diagnosis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Sex Distribution , Telangiectasis/metabolism , Telangiectasis/pathology
17.
Arch Dermatol ; 147(10): 1173-9, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21680758

ABSTRACT

OBJECTIVE: Despite recent advances in our molecular understanding of Spitz-type tumors, the clinical behavior of these lesions remains unclear. We thus set out to define the clinical outcome of classic Spitz nevi, atypical Spitz tumors (ASTs), and spitzoid melanomas. DESIGN: From 1987 through 2002, data on all lesions containing the term "Spitz" or "Spitz" [AND] "melanoma" were retrieved from the pathology database at Massachusetts General Hospital, and the cases were followed up for their outcome. SETTING: The study was performed at a university-affiliated tertiary health care center in Boston, Massachusetts. PATIENTS: A total of 157 patients with Spitz-type melanocytic lesions and follow-up information were identified. MAIN OUTCOME MEASURES: Sentinel lymph node biopsy results, metastases, or fatality were assessed. RESULTS: There were 68 classic Spitz nevi, 76 ASTs, 10 spitzoid melanomas, and 3 melanomas that arose in Spitz nevi. Spitz nevi were diagnosed at a younger age than ASTs (mean age, 26.4 years vs 33.7 years) (P = .01), though both occurred earlier than melanomas (mean age, 50.4 years, P < .001). Sentinel lymph node biopsy findings were positive in 1 of 6 and 4 of 8 patients with ASTs and spitzoid melanomas, respectively. After a median follow-up of 9.1 years, only 1 patient with an AST, who had a separate intermediate-thickness melanoma, developed distant metastasis. There were 6 documented invasive melanomas among 144 patients with classic Spitz nevi or ASTs (observed/expected ratio, 8.03) (P = .01). CONCLUSIONS: Atypical Spitz tumors are associated with minimal lethal potential, an increased melanoma risk, and a moderate risk of metastasis to regional nodes. It makes clinical sense to minimize aggressive treatment but to offer careful surveillance for rare relapses and subsequent melanomas.


Subject(s)
Melanoma/epidemiology , Nevus, Epithelioid and Spindle Cell/epidemiology , Skin Neoplasms/epidemiology , Adolescent , Adult , Aged , Boston/epidemiology , Child , Child, Preschool , Female , Humans , Incidence , Lymphatic Metastasis , Male , Massachusetts/epidemiology , Melanoma/secondary , Melanoma/surgery , Middle Aged , Nevus, Epithelioid and Spindle Cell/pathology , Nevus, Epithelioid and Spindle Cell/surgery , Sentinel Lymph Node Biopsy , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Treatment Outcome , Young Adult
20.
Int J Epidemiol ; 38(4): 978-88, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19416955

ABSTRACT

BACKGROUND: Cancer registries in the 1970s showed that parts of Golestan Province in Iran had the highest rate of oesophageal squamous cell carcinoma (OSCC) in the world. More recent studies have shown that while rates are still high, they are approximately half of what they were before, which might be attributable to improved socio-economic status (SES) and living conditions in this area. We examined a wide range of SES indicators to investigate the association between different SES components and risk of OSCC in the region. METHODS: Data were obtained from a population-based case-control study conducted between 2003 and 2007 with 300 histologically proven OSCC cases and 571 matched neighbourhood controls. We used conditional logistic regression to compare cases and controls for individual SES indicators, for a composite wealth score constructed using multiple correspondence analysis, and for factors obtained from factors analysis. RESULTS: We found that various dimensions of SES, such as education, wealth and being married were all inversely related to OSCC. The strongest inverse association was found with education. Compared with no education, the adjusted odds ratios (95% confidence intervals) for primary education and high school or beyond were 0.52 (0.27-0.98) and 0.20 (0.06-0.65), respectively. CONCLUSIONS: The strong association of SES with OSCC after adjustment for known risk factors implies the presence of yet unidentified risk factors that are correlated with our SES measures; identification of these factors could be the target of future studies. Our results also emphasize the importance of using multiple SES measures in epidemiological studies.


Subject(s)
Carcinoma, Squamous Cell/etiology , Esophageal Neoplasms/etiology , Social Class , Aged , Carcinoma, Squamous Cell/epidemiology , Educational Status , Epidemiologic Methods , Esophageal Neoplasms/epidemiology , Female , Humans , Iran/epidemiology , Male , Middle Aged , Socioeconomic Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...